Each tablet of Equagesic, for oral administration, contains 200 mg meprobamate and 325 mg aspirin.
As an adjunct in the short-term treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. Clinical trials have demonstrated that in these situations relief of pain is somewhat greater than with aspirin alone. Equagesic is not intended for use longer than 10 days.
Media Articles Related to Equagesic (Meprobamate / Aspirin)
A Scientist Shares His Battle to Withdraw From Painkillers
Source: Medscape General Surgery Headlines [2017.01.13]
Travis Rieder spent more than four weeks in hospitals and nearly lost his foot after a van ran a stop sign and struck his motorcycle on Memorial Day weekend in 2015.
Reuters Health Information
Yoga May Ease Pain, Up Function in Chronic Low Back Pain
Source: Medscape NeurologyHeadlines [2017.01.13]
Yoga may improve function and lessen pain in patients with chronic, nonspecific low back pain, a new Cochrane review suggests.
Medscape Medical News
Open-label Placebo Treatment in Chronic Low Back Pain
Source: Medscape Anesthesiology Headlines [2017.01.12]
Can a placebo treatment improve chronic low-back pain--even when the patient is aware that it's a placebo?
Medical News Today: Can yoga help with chronic back pain?
Source: Featured Health News from Medical News Today [2017.01.12]
A new systematic Cochrane review analyzes existing studies on the benefits of yoga for reducing chronic, non-specific lower back pain.
The weather's not to blame for your aches and pains
Source: Arthritis / Rheumatology News From Medical News Today [2017.01.12]
New research from The George Institute for Global Health has revealed the weather plays no part in the symptoms associated with either back pain or osteoarthritis.